The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | |||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | ||||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | FIGI | (to the nearest dollar) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| ACTUATE THERAPEUTICS INC | COM | 005083100 | 11,020,039 | 1,384,427 | SH | DFND | 0 | 1,384,427 | 0 | |||
| ACTUATE THERAPEUTICS INC | COM | 005083100 | 67,733,423 | 8,509,224 | SH | OTR | 1 | 0 | 8,509,224 | 0 | ||
| AILERON THERAPEUTICS INC | COM NEW | 00887A204 | 441,600 | 192,000 | SH | DFND | 0 | 192,000 | 0 | |||
| AILERON THERAPEUTICS INC | COM NEW | 00887A204 | 3,447,127 | 1,498,751 | SH | OTR | 1 | 0 | 1,498,751 | 0 | ||
| COGNITION THERAPEUTICS INC | COM | 19243B102 | 350,717 | 500,095 | SH | DFND | 0 | 500,095 | 0 | |||
| COGNITION THERAPEUTICS INC | COM | 19243B102 | 3,857,083 | 5,499,905 | SH | OTR | 1 | 0 | 5,499,905 | 0 | ||
| IN8BIO INC | COM | 45674E109 | 2,211,920 | 8,600,001 | SH | OTR | 1 | 0 | 8,600,001 | 0 | ||
| LANTERN PHARMA INC | COM | 51654W101 | 3,852,591 | 1,207,709 | SH | OTR | 1 | 0 | 1,207,709 | 0 | ||
| OPUS GENETICS INC | COM | 67577R102 | 2,952,370 | 2,480,983 | SH | OTR | 1 | 0 | 2,480,983 | 0 | ||